Ixekizumab Versus Secukizumab in Over 70-year-old Patients with Psoriasis

NCT06811558 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Over 70-year-old Patients with Psoriasis

Interventions

BIOLOGICAL: Ixekizumab
BIOLOGICAL: Secukizumab

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators

[object Object]